 Inflammatory bowel disease Part Nature pathogenesis medical curiosities ulcerative colitis Crohn disease remarkable change status today compelling human illnesses cause inflammatory bowel disease IBD Genetic environmental microbial immunologic factors precise mechanisms obscure incidence ulcerative colitis stable Crohn disease frequency patients hard ulcerative colitis Crohn colitis problems diagnosis time repeated examinations part two-part monograph IBD Kirsner nature pathogenesis disease study ulcerative colitis Crohn disease recent years new knowledge etiology Part microbial immunologic genetic mechanisms inflammatory processes disease part II next month issue Disease-a-Month Kirsner deals clinical features course management IBD author years experience problems critical examination recent literature Particular attention symptoms physical findings ulcerative colitis Crohn disease laboratory radiologic endoscopic pathologic features many systemic complications IBDs several enterocolonic infections conditions differential diagnosis necessary Inflammatory bowel disease children elderly conforms conventional clinical patterns health circumstances respective age groups cause IBD current medical therapy facilitative supportive principles medical treatment ulcerative colitis Crohn disease Treatment program drug individuality therapeutic response clearer understanding dietary nutritional needs hyperalimentation electrolyte fluid balance aids treatment Antidiarrheal antispasmodic preparations sedatives symptom relief bowel inflammation sulfasalazine salicylic acid compounds antibacterial drugs complications Crohn disease IBD adrenocortical steroids immunosuppressive compounds azathioprine cyclosporine patient surgical procedures available treatment ulcerative colitis total proctocolectomy ileostomy ileoanal anastomosis ABSTRACT TRUNCATED AT WORDS